Skip to main content

Table 1 Patient characteristics (n = 31)

From: Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma

Characteristics No.
Gender
 Male 22 (71%)
 Female 9 (29%)
Performance status
 0 17 (55%)
 1 12 (39%)
 2 2 (6%)
Child-Pugh classification
 A 27 (87%)
 B 4 (13%)
MELD score
 6–7 17 (55%)
 8–9 11 (35%)
 10 ≤ 3 (10%)
Viral marker
 HBs-Ag (+), HCV-Ab (−) 2 (6%)
 HBs-Ag (−), HCV-Ab (+) 18 (58%)
 HBs-Ag (+), HCV-Ab (+) 1 (3%)
 HBs-Ag (−), HCV-Ab (−) 10 (33%)
Co-morbidity
 Diabetes mellitus 10 (33%)
 Hypertension 16 (52%)
 Cardiovascular disease 8 (26%)
 Respiratory disease 5 (16%)
 Chronic renal failure 2 (6%)
 Brain disease 2 (6%)
Tumor size, mm, median [range] 45 [15–93]
Serum AFP level, ng/ml, median [range] 7.3 [1.3–48,058.3]
Serum AFP-L3, %, median [range] 3.1 [< 0.5–84.2]
Serum PIVKA-II level, mAU/ml, median [range] 85 [10–19,937]
Stage (UICC 7th edition)
 I 24 (77%)
 II 4 (14%)
 III 3 (9%)
Stage (BCLC)
 A 13 (42%)
 B 1 (3%)
 C 17 (55%)
  1. Abbreviations: MELD = Model for end-stage liver disease, HBs-Ag = Hepatitis B surface antigen, HCV-Ab = Hepatitis C virus antibody, AFP = Alpha-fetoprotein, AFP-L3 = Lens culinaris agglutinin-reactive fraction of AFP, PIVKA-II = Protein induced by vitamin K, AU = Arbitrary unit, UICC = Union for International Cancer Control classification, BCLC = Barcelona Clinic Liver Classification